MedPath

Comparison The Effect of Ventolin Nebulizer With And Without Hypertonic Saline% 3 On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease

Phase 1
Conditions
Chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease, unspecified
J44.9
Registration Number
IRCT20181205041858N1
Lead Sponsor
Gonabad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Participate in research.
Be alert
Be known to be COPD or hospitalized with this diagnosis
Have moderate or high dyspnea (at least scale 3 of the bourgeois scale)
Nebulizer Ventolin in patient medication orders which have been ordered by a Internal specialist.

Exclusion Criteria

Patient's death or decreased level of consciousness during treatment
After diagnosis, the patient's shortness of breath is due to myocardial infarction, myocardial infarction, or congestive heart failure.
Patient's unwillingness to continue research

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dyspnea. Timepoint: Before and 24, 48 hours after intervention. Method of measurement: Borg scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath